End-stage liver disease in persons with hemophilia and transfusion-associated infections

Blood

Volumn 100, Issue 5, 2002, Pages 1584-1589

  Goedert, James J ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q}   Elaine Eyster, M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Lederman, Michael M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Mandalaki, Titica ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   De Moerloose, Philippe ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   White II, Gilbert C ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Angiolillo, Anne L ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Luban, Naomi L C ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Sherman, Kenneth E ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Manco Johnson, Marilyn ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Preiss, Liliana ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Leissinger, Cindy ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Kessler, Craig M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Cohen, Alan R ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Dimichele, Donna ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Hilgartner, Margaret W ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Aledort, Louis M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Kroner, Barbara L ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Rosenberg, Philip S ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}   Hatzakis, Angelos ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p}  

^a NATIONAL CANCER INSTITUTE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LAIKO GENERAL HOSPITAL   (Greece)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^h UNIVERSITY OF CINCINNATI   (United States)

ⁱ Mountain States Regional Hemophilia and Thrombosis Center   (United States)

^j RTI INTERNATIONAL   (United States)

^k TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^m CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

ⁿ NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^o MOUNT SINAI MEDICAL CENTER   (United States)

^p UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^q NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; MEMBRANE ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; HEMOPHILIA; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; POSTTRANSFUSION HEPATITIS; PRIORITY JOURNAL; RISK ASSESSMENT; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGE FACTORS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMOPHILIA A; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; LIVER FAILURE, ACUTE; MALE; PROSPECTIVE STUDIES;

EID: 0036721470     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
2. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis
3. Natural history of hepatitis C
4. Clinical outcomes after transfusion-associated hepatitis C
5. Non-A, non-B post-transfusion hepatitis: Looking back in the second decade
6. Hepatitis C and hepatocellular carcinoma
7. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis
8. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2215 patients
9. Hepatitis C antibody and chronic liver disease in haemophilia
10. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients
11. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus
12. A multicenter study of viral hepatitis in a United States hemophilic population
13. Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non-virus inactivated factor VIII and IX concentrates
14. A study of liver biopsies and liver disease among hemophiliacs
15. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis
16. The progression of HCV-associated liver disease in a cohort of haemophilic patients
17. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV
18. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C
19. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985
20. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia
21. HIV-1 infection incidence among persons with hemophilia in the United States and Western Europe, 1978-1990
22. Hazard function estimation using B-splines
23. On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data
24. A class of K-sample tests for comparing the cumulative incidence of a competing risk
25. Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Multicenter Hemophilia Cohort Study
26. National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups
27. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia
28. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease
29. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan
30. Natural history of liver fibrosis progression in patients with chronic hepatitis C: The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups
31. Changes in liver histopathology in women infected with hepatitis C through contaminated anti-D immunoglobulin injections in Ireland
32. Long-term mortality after transfusion-associated non-A, non-B hepatitis
33. Immunology of viral hepatitis
34. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C
35. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis
36. Estimating the cumulative incidence of HIV infection among persons with haemophilia in the United States of America